Clinical Trials Logo

Hospital Acquired Infection clinical trials

View clinical trials related to Hospital Acquired Infection.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05522725 Completed - Clinical trials for Hospital Acquired Infection

The Impact of Bedside Wipes in Multi-patient Rooms: a Prospective, Crossover Trial Evaluating Infections and Survival

Start date: October 20, 2016
Phase: N/A
Study type: Interventional

Multidrug resistant organisms (MDRO) are prevalent in hospitals and are associated with hospital-acquired infections (HAI). High-touch surfaces serve as reservoirs and fomites for MDRO transmission. The investigators quantified the impact of hanging single-use cleaning/disinfecting wipes in patients' immediate environment within multi-patient rooms. Pre-specified outcomes were: 1) HAI rate, 2) cleaning frequency, 3) MDRO room contamination, 4) new MDRO acquisitions, and 5) in-hospital mortality.

NCT ID: NCT05055479 Completed - Clinical trials for Enterobacteriaceae Infections

Nosocomial Outbreak of BHRe in an Intensive Care Unit During SARS-CoV-2 Pandemic

BHReICU
Start date: August 1, 2021
Phase:
Study type: Observational

Multidrug Resistant (MDR) bacteria have become a major worldwide public health challenge and hospitals are now increasingly faced with management of local outbreaks involving such pathogens. Especially, intensive care units (ICU) provide an ideal background for outbreaks caused by MDR bacteria among which carbapenemase-producing Enterobacteriaceae (CPE) can be found. Among CPE involved in ICU outbreaks, VIM producers have been reported worldwide, and described as especially difficult to control. The COVID-19 pandemic and all of the measures health workers have to implement to fight the spread of SARS-Cov-2 have also impacted the management of such outbreaks. In this retrospective study, the investigators aim to describe the management of an outbreak caused by a VIM-producing Enterobacter cloacae strain during the 2020 COVID-19 pandemic in an ICU, and show the importance of concerted measures and actions implemented at multiple levels to prevent the spread of this MDR strain.

NCT ID: NCT04954300 Completed - Clinical trials for Hospital Acquired Infection

Investigation on the Dynamic Changes in Air Microbiome in Intensive Care Unit

Start date: February 1, 2021
Phase:
Study type: Observational

The microbiome of ICU, especially the air microbiome of ICU is not clear. The relationship between the microbiome of ICU and the hospital- acquired infection needs to be clarified. In this study, we try to outline the dynamic changes of microbiome in ICU and give some advice on the prevention of HAI.

NCT ID: NCT02966392 Completed - Clinical trials for Mechanical Ventilation Complication

Continuous Endotracheal Cuff Pressure Control to Prevent Ventilator Associated Respiratory Infections

VARI-prevent
Start date: November 1, 2016
Phase: N/A
Study type: Interventional

The purpose of the study is to determine whether automated cuff pressure control results in a reduction in the proportion of patients developing ventilator associated respiratory infections during their stay in intensive care.

NCT ID: NCT02351895 Completed - Clinical trials for Hospital Acquired Infection

Effect of Copper Impregnated Textiles on Healthcare Associated Infections and Antibiotic Use

Start date: January 2014
Phase: N/A
Study type: Observational

This is a prospective Infection Control study comparing rates of antibiotic usage and infections in the General Intensive Care Unit (GICU) in beds with copper impregnated linens versus regular linens.